Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Healthcare insurer stocks mixed after Aetna, Humana deal

By Pharmaceutical Processing | July 6, 2015

This Aug. 8, 2011 file photo shows the entrance to the Humana building in Louisville, Ky. Health insurer Aetna Inc. has made a deal to buy competitor Humana Inc. in a $37 billion deal the companies say would create the second-largest managed care company, it was announced Friday, July 3, 2014. (AP Photo/Ed Reinke, File)NEW YORK (AP) — In the first day of trading since Aetna announced a deal buy Humana last week, stocks of health care insurers were mixed Monday.

Aetna offered about $35 billion to buy rival Humana on Friday, a day when U.S. stock markets were closed in observance of Independence Day.

The proposed deal between Aetna and Humana follows others in the industry, as they respond to the Affordable Care Act. Also last week, Medicaid coverage provider Centene said it would spend $6.3 billion to buy Health Net. And last month, Anthem offered to buy Cigna for more than $47 billion.

Here’s how the stocks of some health insurers fared in afternoon trading Monday:

— Aetna Inc. shares fell $7.05, or 5.6 percent, to $118.46.

— Anthem Inc. shares fell $1.14 to $162.

— Centene Corp. shares fell $ 2.14, or 2.9 percent, to $72.30.

— Cigna Corp. shares fell 71 cents to $160.58.

— Health Net Inc. shares fell $1.80, or 2.5 percent, to $69.77.

— Humana Inc. shares rose $5.49, or 2.9 percent, to $192.99.

— Molina Healthcare Inc. shares rose $ 1.08, or 1.6 percent, to $70.44.

— UnitedHealth Group Inc. shares rose 64 cents to $122.45.

— WellCare Health Plans Inc. shares rose $ 1.77, or 2.1 percent, to $88.19.

Related Articles Read More >

Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE